Nithe i dtosach suíonna - Commencement Matters ›
Women's Health
Senator Joanne Collins urged immediate disclosure of breast density to women, arguing dense tissue can obscure cancer and patients need the information to make informed choices. The Government cited an ongoing HIQA assessment, due before the end of 2027, and made no immediate commitment, saying changes must be evidence-based and clinically appropriate.
Today, I wish to raise a couple of questions and statistics on breast density. A lot of my colleagues across this House and the other House have often spoken about breast density. There was a briefing in the audiovisual room last week on this topic, which was quite harrowing and tear-jerking. If you had any heart, you would not have left with a dry eye having listened to what these women have been through.
The data shows that up to 43% of women have dense breasts. When women get to a certain age they are entitled to a mammogram. When they go for that mammogram, a cancer shows up as white, but dense breast tissue also shows up as white; therefore, it is impossible for a radiographer to see if there is cancer there or not. We had a radiographer in the audiovisual room last week and she said it is impossible and there is no way to determine whether a person with dense breast tissue has cancer or not. Also, quite shockingly, they do not tell the patient if she has dense breasts or not, so the patient is going away with a clear mammogram, thinking that everything is fine. Down the line, these women end up going back for appointments and are eventually told they have cancer and it has been there all along. It may now be at stage 3, stage 4, or inoperable; what might have been a lumpectomy becomes a full mastectomy requiring chemotherapy. The cost, the strain on the family and the strain on the patient is all because they are not given that one piece of information. That one piece of information is not going to cost the HSE or the State one penny. It is just a matter of giving information to a patient to say they have or do not have dense breasts.
I have just been looking at the HSE's website. It states:
Dense breasts are common. About half of all women have dense breasts. Breast density is non-fatty breast tissue and is one of the risk factors for breast cancer. The advice for all women, whether you have dense breasts or not, is to be breast aware and talk to your GP ...
However, being breast aware is not good enough when it comes to this because if a mammogram cannot show it up, a self-check is not going to show it up. It is not going to give that information. A GP cannot tell the person they have cancer or do not have cancer because they only have a mammogram. If these women are given the information and are just told they have dense breasts, they can then go themselves and request a computed tomography scan or whatever next is in line. That way they know for themselves. We all love to see a positive response from a doctor or scan, but to have that false positive or possible false positive can be very worrying. We met women and the line they all used is, "Tell me I have dense breasts before you tell me I have cancer." It is very simple. As I said, there is no cost to the State for this.
It is basically about giving us the information that we own ourselves. It is our information. It is the patient's information.
Comment on this
I thank Senator Collins for giving me the opportunity to discuss this really important matter and for highlighting the concerns of women and advocacy groups. I am taking this matter on behalf of the Minister for Health, Deputy Carroll MacNeill. Enhancing Ireland's population screening programmes is a priority for the Minister. The programmes are a vital component of our health services.
Dense breast tissue is common. Around half of all women have dense breasts and it is a normal variation in breast tissue. It is very important to say that having dense breasts does not mean a woman will develop breast cancer. BreastCheck mammograms remain the best screening test available for population breast screening for women aged 50 to 69. It can save lives by finding many cancers early, often before symptoms develop. It is important to point out that mammography detects the majority of breast cancers, including in women with dense breasts.
Consideration of any changes to Ireland's screening programmes is facilitated through established evidence-driven protocols. The national screening advisory committee, NSAC, is the expert group that advises the Minister on any proposed changes to Ireland's screening programmes. At the request of that committee, the Health Information and Quality Authority, HIQA, has commenced a health technology assessment, HTA, to consider proposals for the expansion of the BreastCheck programme. This review comprises three distinct components. One is the proposed extension of the age range eligibility to those aged 45 to 49. Another is the extension of age range to those aged between 70 and 74. The third element is the potential introduction of a standardised breast density notification. HTAs facilitate the assessment of relevant evidence on the effects and consequences of healthcare technologies or programmes. They seek to guide decisions regarding the appropriate use of technology and efficient allocation of resources. It is expected that the final HIQA HTA report on all three elements will be submitted to the NSAC before the end of 2027. Once received, the committee will consider the findings and make a recommendation to the Minister.
The introduction or expansion of any new screening service requires careful consideration, particularly when we are considering all the clinical, ethical, societal, legal and economic perspectives. The Minister for Health wishes to develop services that are clinically effective and have positive health outcomes and she needs to be informed by the experts in order to do this. This is particularly relevant in the context of significant differences in international clinical opinion on the incorporation of breast density notification into screening. This emphasises the need for an evidence-led approach to ensure that any decision serves the best interests of Irish women.
Comment on this
I thank the Minister of State for the response and for taking this matter on behalf of the Minister for Health. I believe that BreastCheck needs to be expanded and I have called for that in the past. We should bring the age range down because women can still get cancer at a younger age. It is not just an issue for women or men over 50. However, I am not actually asking for that today as that does cost money.
It is a shame that it will be the end of 2027 before the HIQA report is finalised. That is another full year of women going for mammograms who will not know whether they have cancer or not. All I am asking for today is that the Minister tell the HSE, radiographers, surgeons and GPs that they can tell patients if they have dense breasts. Just tell them; it does not cost anything. It should not take another year and two or three months for us to decide that they can give that information to patients. It is going to take that long for the HIQA report to be finalised, which is probably going to say that we should tell the patients. It is very simple. Information sharing is all that I am asking for. I agree that we need to expand our screening services. That is definitely something that has to happen but today, all I am asking for is a commitment from the Minister to put it in writing that patients can be told that they have dense breasts. That will give them the opportunity to decide themselves if they want to get a CT scan to see if there is cancer there.
Comment on this
Again, I thank the Senator and acknowledge the genuine concerns she is raising on behalf of the many women who want this information. They want certainty and they want to have enhanced confidence in the decisions being made in the national screening programme. As I said, I am not dismissing the concerns and the Minister is not dismissing them either. There is a process in regard to how this can be incorporated into the national screening programme in a way that is clinically appropriate and delivers the best outcomes for patients. We have a process now. HIQA is working on the HTA. I understand the concerns raised by the Senator and I will relay her views to the Minister for Health in the context of actions that can be taken to further strengthen confidence in the programme.